Short Communication Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/rehabilitation.1.004
Exercise-induced left ventricular trabeculation: what’s the evidence?
Andrew D’Silva1,2,*
- 1Department of Cardiology and Division of Cardiovascular Sciences, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London, United Kingdom
- 2Division of Imaging Sciences and Biomedical Engineering, King’s College London, London, United Kingdom
Corresponding Author
Andrew D’Silva, andrew.dsilva@gstt.nhs.uk
Received Date: July 06, 2020
Accepted Date: July 25, 2020
D’Silva A. Exercise-induced left ventricular trabeculation: what’s the evidence?. J Rehabil Res Pract 2020; 1(1):8-10.
Copyright: © 2020 D’Silva A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Exercise-induced left ventricular trabeculation: what’s the evidence?
Cross-sectional studies and small case series have suggested that increased left ventricular (LV) trabeculation may be a manifestation of benign athletic remodeling in predisposed individuals. Interestingly, there is some support that increased LV trabeculation may improve cardiac performance through increases in stroke volume, stroke work and cardiac index (preprint).
Immune checkpoint inhibitor therapy-associated myocarditis – Toward identification of an immune signature that can improve diagnosis
Immune checkpoint inhibitors (ICI) have emerged as promising treatment options for many cancers. ICIs exert their therapeutic effects by targeting immune inhibitory molecules on T-cells in adaptive immunity, such as cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death 1 (PD-1) and its ligand programmed cell death ligand 1 (PD-L1). ICIs, however, can result in a wide variety of immune-related adverse events (iRAE), including myocarditis, a rare and potentially deadly complication that necessitates early diagnosis.
Machine learning methods for prostate cancer diagnosis
Prostate cancer (Pca) is one of the most common cancers among men worldwide. The current screening methods lack effectiveness such as prostate-specific antigen (PSA) and Magnetic resonance imaging (MRI), and some others come with pain such as biopsy. Understanding the genomic behavior of the disease may play a key part in designing more effective, accurate, and less invasive diagnosis measures. Pca has many clinical features to describe the spread and the aggressiveness of the tumor including Gleason score, TNM staging system, and the location of the tumor in the prostate gland which is known as laterality.
Advancing AI in MRI interpretation for temporomandibular disorders: a new era of diagnosis
Temporomandibular disorders (TMDs) have long sat at the uncomfortable intersection between diagnostic ambiguity and therapeutic uncertainty [1–3]. Magnetic Resonance Imaging (MRI) has been the gold standard for assessing articular disc position, morphology, and early soft-tissue changes [4–6]. Yet despite its value, interpretation remains dependent on expert skill, institutional resources, and considerable time investment.